Short Interest Update on C.R. Bard (BCR)

C.R. Bard (BCR) : The bears are holding on to their shorts in Accenture Plc with 3 more days remaining for them to cover their positions. The bearish positions have increased from 1,169,253 on Jul 29, 2016, to 1,421,653, on August 15, 2016. Daily, 417,943 shares are traded, which shows the high interest of the traders in the stock. The net addition of short open interest is 252,400 shares, which is an increase of just 21.6%. The total short interest of 1.9% of the float indicates that there arent many bears on this stock at the current prices. The short interest information was released on Wednesday Aug 24th after the market close.

C.R. Bard (NYSE:BCR): The stock opened at $217.93 on Wednesday but the bulls could not build on the opening and the stock topped out at $218.13 for the day. The stock traded down to $214.74 during the day, due to lack of any buying support eventually closed down at $215.00 with a loss of -1.23% for the day. The stock had closed at $217.68 on the previous day. The total traded volume was 383,547 shares.


In a related news, Holland Christopher S, officer (Senior Vice President and CFO) of Bard C R Inc /Nj/, unloaded 3,970 shares at an average price of $219.88 on May 27, 2016. The total amount of the transaction was worth $872,924, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.

C. R. Bard, Inc. (Bard) and its subsidiaries are engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. . The Company reports its sales in four major product group categories: vascular, urology, oncology and surgical specialty. The Company also has a product group of other products. The Companys vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and heart arrhythmias. Its urology products include basic urology drainage products, fecal and urinary continence products, urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers and other diseases and disorders. Its surgical specialty products include implanted patches and fixation devices for hernia and other soft tissue repairs, in addition to hemostats and surgical sealants.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.